Veracyte Stock (NASDAQ: VCYT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 967.36K |
Day Range | - - - |
52 Wk Range | 18.61 - 35.51 |
Market Cap | $2.68B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 4.25% |
Days to Cover | 4.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Other companies in Veracyte’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
Veracyte has a consensus price target of $32.17.
The stock price for Veracyte (NASDAQ: VCYT) is $34.83 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Veracyte.
Veracyte’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Veracyte.
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.